Fungal sepsis: optimizing antifungal therapy in the critical care setting.
about
Invasive candidiasis as a cause of sepsis in the critically ill patientCandida albicans Biofilms and Human DiseaseEarly diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis.Microbiological profile of organisms causing bloodstream infection in critically ill patientsT cells from patients with Candida sepsis display a suppressive immunophenotypeReductions in Sepsis Mortality and Costs After Design and Implementation of a Nurse-Based Early Recognition and Response Program.Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis.Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.Septic shock attributed to Candida infection: importance of empiric therapy and source control.Problems related to antifungal prescription: a qualitative study of the views of intensivists.Clinical isolates of Candida albicans, Candida tropicalis, and Candida krusei have different susceptibilities to Co(II) and Cu(II) complexes of 1,10-phenanthroline.Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.
P2860
Q22305429-324770C7-57B0-4151-A87B-563D6E9193A6Q26778729-6565D721-B1C4-4AB7-968F-07010115F6B3Q35908296-AFCD4E0B-3FFB-4ACA-BBA1-1624289F8BF4Q36379309-1C6A99E4-20BB-43C5-A020-C79A43A4E30EQ36442068-3CB6B115-43CF-460D-8960-306E0039D56EQ36480729-F98591C0-0947-416F-BA8A-708395B677E0Q36935162-B321ED6A-DEA7-4BE4-AA45-A503C0F89FD1Q36997987-9083145D-80A2-41C8-86BD-2C8A118834E0Q38149163-A0CDDAEF-050C-4EC2-9205-53C12131F510Q39092240-6CCC44B6-53C8-4B1F-9EBF-0F626A344B6FQ40026437-1C5FFB09-6EE2-4C50-B35A-A749BD6CD7C8Q45895673-6AF52CF3-C2F6-4713-83DD-7B0F9596F07AQ46775225-44B5F45A-A015-41C6-A833-14B8BA3E4454Q46876288-10146A74-A784-4857-8CB1-84929CAB646A
P2860
Fungal sepsis: optimizing antifungal therapy in the critical care setting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fungal sepsis: optimizing antifungal therapy in the critical care setting.
@en
Fungal sepsis: optimizing antifungal therapy in the critical care setting.
@nl
type
label
Fungal sepsis: optimizing antifungal therapy in the critical care setting.
@en
Fungal sepsis: optimizing antifungal therapy in the critical care setting.
@nl
prefLabel
Fungal sepsis: optimizing antifungal therapy in the critical care setting.
@en
Fungal sepsis: optimizing antifungal therapy in the critical care setting.
@nl
P1476
Fungal sepsis: optimizing antifungal therapy in the critical care setting.
@en
P2093
Alexander Lepak
David Andes
P304
P356
10.1016/J.CCC.2010.11.001
P577
2011-01-01T00:00:00Z